-
Signature
-
/s/ Elizabeth Feeney, Attorney-In-Fact
-
Issuer symbol
-
INCY
-
Transactions as of
-
10 Dec 2025
-
Transactions value $
-
-$554,965
-
Form type
-
4
-
Filing time
-
12 Dec 2025, 16:01:54 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Mayes Patrick A |
EVP & Chief Scientific Officer |
1801 AUGUSTINE CUT-OFF, WILMINGTON |
/s/ Elizabeth Feeney, Attorney-In-Fact |
12 Dec 2025 |
0002079962 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
INCY |
Common Stock |
Sale |
-$531K |
-5.55K |
-8.44% |
$95.58 |
60.3K |
10 Dec 2025 |
Direct |
|
| transaction |
INCY |
Common Stock |
Sale |
-$24.2K |
-255 |
-0.42% |
$94.94 |
60K |
11 Dec 2025 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: